Completed PHASE3 INTERVENTIONAL 2-arm NCT01550809

New Strategies for Postprandial Glycemic Control Using Insulin Pump Therapy

New Strategies for Postprandial Glycemic Control Using Insulin Pump Therapy: Feasibility of Insulin Dosing Based on Information From Continuous Glucose Monitoring

Sponsor: European Union

Conditions Type 1 Diabetes

Interventions iBolus tBolus (traditional bolus)

Updated 7 times since 2017 Last updated: Aug 20, 2012 Started: Feb 28, 2010 Primary completion: Jun 30, 2011 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Type 1 Diabetes, this trial is completed. The trial is conducted by European Union and has accumulated 7 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE3
Jan 2021 — Dec 2022 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Union
Fundación para la Investigación del Hospital Clínico de Valencia
Ministerio de Ciencia e Innovación, Spain

Data source: Fundación para la Investigación del Hospital Clínico de Valencia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Valencia, Spain